PATENT CLAIM ANALYSIS

Application Number: 15861586
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "349000"]

Abstract:
The present invention provides a compound which is: tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alaninate or a salt, hydrate or solvate thereof. The present invention also provides a pharmaceutical composition comprising the compound together with one or more pharmaceutically acceptable carriers and/or excipients. The compound and composition are useful for inhibiting the activity of a p38 MAP kinase enzyme. As such they may be used in the treatment of a autoimmune or inflammatory disease, or a cell proliferative disease. In addition, the invention provides an acid produced by hydrolysis of the ester group of the compound of the invention. The acid is N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl)-L-alanine.

Claim (Index 15):
A method according to  claim 13  or  claim 14  for the treating, ameliorating or reducing the incidence of breast cancer, ovarian cancer, pancreatic cancer, lung cancer, colon cancer, renal cancer, lymphoma or melanoma.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.80488
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15183612', '14436404', '12299333', '12867774', '13707326']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7713616439169161
- 35 USC 102 Novelty (BERT): 0.5469422315516536
- Combined Prediction Score: 0.7489197026803899
- Mean Citation Score: 334.035562
- Max Citation Score: 390.14536
- Similarity Product: 242.7178913735866

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test